GET THE APP

Molecular docking studies of quinoline-3-carbohydrazide as novel PTP1B inhibitors as potential antihyperglycemic agents | Abstract

Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry

ISSN: 0975-413X
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission Systemof respective journal.

Abstract

Molecular docking studies of quinoline-3-carbohydrazide as novel PTP1B inhibitors as potential antihyperglycemic agents

Author(s): Rohan V. Bamane, Trupti S. Chitre, Vijay K. Rakholiya

Binding modes of a series of quinoline-3-carbohydrazide as protein tyrosine phosphatase 1B (PTP 1B) inhibitors have been identified by molecular modeling techniques. We have performed docking and ADME predictions of these inhibitors with PTP 1B enzyme. As per our literature, we found that PTP1B is highly hydrophobic. The results indicate that quinoline-3- carbohydrazide for addition to hydrogen bonding interactions, Arg24, Asp48, Glu115, Lys116, Lys120, Cys215, Ser216, Ala217 amino acid residues of PTP 1B are responsible for governing inhibitor potency of the compounds. ADME predictions of 6 top selected compounds were done with Qikprop 3.2 tool available in Schrödinger 9.0 ver. The information generated from the present study should be useful in the design of more potent PTP1B inhibitors as antidiabetic agents.


PDF

Select your language of interest to view the total content in your interested language

30+ Million Readerbase
SCImago Journal & Country Rank
Google Scholar citation report
Citations : 25868

Der Pharma Chemica received 25868 citations as per Google Scholar report

Der Pharma Chemica peer review process verified at publons
Der Pharma Chemica- Journals on pharmaceutical chemistry